# Clarus Corp: financial statements, quarterly

CLAR · Nasdaq · CIK 913277 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/clar.md) · [Financials](/companies/clar/financials.md) · [Filings](/companies/clar/filings.md) · [Insiders](/companies/clar/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/clar/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [81.3](/filings/0001558370-24-014902.md) | [76.5 d](/filings/0001104659-26-024159.md) | [69.3](/filings/0001558370-25-006998.md) | [56.5](/filings/0001558370-25-009892.md) | [67.1](/filings/0001104659-25-107793.md) | [71.4 d](/filings/0001104659-26-024159.md) | [60.4](/filings/0001104659-26-057191.md) | [55.2](/filings/0001104659-26-092074.md) | [69.3](/filings/0001104659-25-107793.md) | [65.4 d](/filings/0001104659-26-024159.md) | [61.9](/filings/0001104659-26-057191.md) | [56.2](/filings/0001104659-26-092074.md) |
| Cost of revenue | $m | [54.0](/filings/0001558370-24-014902.md) | [54.4 d](/filings/0001104659-26-024159.md) | [44.5](/filings/0001558370-25-006998.md) | [36.1](/filings/0001558370-25-009892.md) | [43.6](/filings/0001104659-25-107793.md) | [47.5 d](/filings/0001104659-26-024159.md) | [39.6](/filings/0001104659-26-057191.md) | [35.6](/filings/0001104659-26-092074.md) | [45.0](/filings/0001104659-25-107793.md) | [47.3 d](/filings/0001104659-26-024159.md) | [39.2](/filings/0001104659-26-057191.md) | [28.7](/filings/0001104659-26-092074.md) |
| Gross profit | $m | [27.3](/filings/0001558370-24-014902.md) | [22.1 d](/filings/0001104659-26-024159.md) | [24.9](/filings/0001558370-25-006998.md) | [20.4](/filings/0001558370-25-009892.md) | [23.5](/filings/0001104659-25-107793.md) | [23.9 d](/filings/0001104659-26-024159.md) | [20.8](/filings/0001104659-26-057191.md) | [19.7](/filings/0001104659-26-092074.md) | [24.4](/filings/0001104659-25-107793.md) | [18.1 d](/filings/0001104659-26-024159.md) | [22.8](/filings/0001104659-26-057191.md) | [27.5](/filings/0001104659-26-092074.md) |
| Selling, general and administrative | $m | [28.4](/filings/0001558370-24-014902.md) | [30.0 d](/filings/0001104659-26-024159.md) | [28.2](/filings/0001558370-25-006998.md) | [28.1](/filings/0001558370-25-009892.md) | [27.9](/filings/0001104659-25-107793.md) | [27.8 d](/filings/0001104659-26-024159.md) | [26.6](/filings/0001104659-26-057191.md) | [26.9](/filings/0001104659-26-092074.md) | [26.2](/filings/0001104659-25-107793.md) | [25.5 d](/filings/0001104659-26-024159.md) | [26.6](/filings/0001104659-26-057191.md) | [24.3](/filings/0001104659-26-092074.md) |
| Operating income | $m | [(3.2)](/filings/0001558370-24-014902.md) | [(10.1) d](/filings/0001104659-26-024159.md) | [(6.8)](/filings/0001558370-25-006998.md) | [(8.1)](/filings/0001558370-25-009892.md) | [(5.4)](/filings/0001104659-25-107793.md) | [(50.1) d](/filings/0001104659-26-024159.md) | [(6.8)](/filings/0001104659-26-057191.md) | [(10.9)](/filings/0001104659-26-092074.md) | [(3.0)](/filings/0001104659-25-107793.md) | [(39.0) d](/filings/0001104659-26-024159.md) | [(6.1)](/filings/0001104659-26-057191.md) | [4.6](/filings/0001104659-26-092074.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(1.4)](/filings/0001558370-24-014902.md) | [(1.7) d](/filings/0001104659-26-024159.md) | [(0.9)](/filings/0001558370-25-006998.md) | [(1.8)](/filings/0001558370-25-009892.md) | [(0.7)](/filings/0001104659-25-107793.md) | [21.1 d](/filings/0001104659-26-024159.md) | [(0.8)](/filings/0001104659-26-057191.md) | [(0.8)](/filings/0001104659-26-092074.md) | [(2.2)](/filings/0001104659-25-107793.md) | [(6.7) d](/filings/0001104659-26-024159.md) | [0.2](/filings/0001104659-26-057191.md) | [0.0](/filings/0001104659-26-092074.md) |
| Net income | $m | [(1.3)](/filings/0001558370-24-014902.md) | [(8.4) d](/filings/0001104659-26-024159.md) | [21.9](/filings/0001104659-25-107793.md) | [(5.5)](/filings/0001104659-25-107793.md) | [(3.2)](/filings/0001104659-25-107793.md) | [(65.5) d](/filings/0001104659-26-024159.md) | [(5.2)](/filings/0001104659-26-092074.md) | [(8.4)](/filings/0001104659-26-092074.md) | [(1.6)](/filings/0001104659-25-107793.md) | [(31.3) d](/filings/0001104659-26-024159.md) | [(3.3)](/filings/0001104659-26-092074.md) | [4.7](/filings/0001104659-26-092074.md) |
| Diluted EPS | $ per share | [(0.03)](/filings/0001558370-24-014902.md) | not reported | [0.57](/filings/0001558370-25-006998.md) | [(0.14)](/filings/0001558370-25-009892.md) | [(0.08)](/filings/0001104659-25-107793.md) | not reported | [(0.14)](/filings/0001104659-26-057191.md) | [(0.22)](/filings/0001104659-26-092074.md) | [(0.04)](/filings/0001104659-25-107793.md) | not reported | [(0.09)](/filings/0001104659-26-057191.md) | [0.12](/filings/0001104659-26-092074.md) |
| Basic EPS | $ per share | [(0.03)](/filings/0001558370-24-014902.md) | not reported | [0.57](/filings/0001558370-25-006998.md) | [(0.14)](/filings/0001558370-25-009892.md) | [(0.08)](/filings/0001104659-25-107793.md) | not reported | [(0.14)](/filings/0001104659-26-057191.md) | [(0.22)](/filings/0001104659-26-092074.md) | [(0.04)](/filings/0001104659-25-107793.md) | not reported | [(0.09)](/filings/0001104659-26-057191.md) | [0.12](/filings/0001104659-26-092074.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [8.0](/filings/0001558370-23-018008.md) | [11.3](/filings/0001558370-25-002405.md) | [47.5](/filings/0001558370-24-006566.md) | [46.2](/filings/0001558370-24-010612.md) | [36.4](/filings/0001558370-24-014902.md) | [45.4](/filings/0001104659-26-024159.md) | [41.3](/filings/0001558370-25-006998.md) | [28.5](/filings/0001558370-25-009892.md) | [29.5](/filings/0001104659-25-107793.md) | [36.7](/filings/0001104659-26-092074.md) | [29.8](/filings/0001104659-26-057191.md) | [28.9](/filings/0001104659-26-092074.md) |
| Current assets | $m | [231](/filings/0001558370-23-018008.md) | [300](/filings/0001558370-25-002405.md) | [197](/filings/0001558370-24-006566.md) | [189](/filings/0001558370-24-010612.md) | [192](/filings/0001558370-24-014902.md) | [178](/filings/0001104659-26-024159.md) | [178](/filings/0001558370-25-006998.md) | [176](/filings/0001558370-25-009892.md) | [175](/filings/0001104659-25-107793.md) | [171](/filings/0001104659-26-092074.md) | [167](/filings/0001104659-26-057191.md) | [174](/filings/0001104659-26-092074.md) |
| Total assets | $m | [497](/filings/0001558370-23-018008.md) | [495](/filings/0001558370-25-002405.md) | [377](/filings/0001558370-24-006566.md) | [369](/filings/0001558370-24-010612.md) | [375](/filings/0001558370-24-014902.md) | [294](/filings/0001104659-26-024159.md) | [293](/filings/0001558370-25-006998.md) | [287](/filings/0001558370-25-009892.md) | [283](/filings/0001104659-25-107793.md) | [249](/filings/0001104659-26-092074.md) | [243](/filings/0001104659-26-057191.md) | [255](/filings/0001104659-26-092074.md) |
| Current liabilities | $m | [63.9](/filings/0001558370-23-018008.md) | [171](/filings/0001558370-25-002405.md) | [36.1](/filings/0001558370-24-006566.md) | [32.9](/filings/0001558370-24-010612.md) | [36.0](/filings/0001558370-24-014902.md) | [36.0](/filings/0001104659-26-024159.md) | [40.0](/filings/0001558370-25-006998.md) | [38.6](/filings/0001558370-25-009892.md) | [37.5](/filings/0001104659-25-107793.md) | [40.5](/filings/0001104659-26-092074.md) | [38.0](/filings/0001104659-26-057191.md) | [39.0](/filings/0001104659-26-092074.md) |
| Total liabilities | $m | [206](/filings/0001558370-23-018008.md) | [203](/filings/0001558370-25-002405.md) | [66.6](/filings/0001558370-24-006566.md) | [62.1](/filings/0001558370-24-010612.md) | [66.9](/filings/0001558370-24-014902.md) | [61.0](/filings/0001104659-26-024159.md) | [63.5](/filings/0001558370-25-006998.md) | [61.4](/filings/0001558370-25-009892.md) | [57.3](/filings/0001104659-25-107793.md) | [52.6](/filings/0001104659-26-092074.md) | [49.6](/filings/0001104659-26-057191.md) | [56.8](/filings/0001104659-26-092074.md) |
| Long-term debt | $m | [110](/filings/0001558370-23-018008.md) | [120](/filings/0001558370-25-002405.md) | [0.0](/filings/0001558370-24-006566.md) | not reported | not reported | [1.9](/filings/0001104659-26-024159.md) | [1.9](/filings/0001558370-25-006998.md) | [1.9](/filings/0001558370-25-009892.md) | [2.0](/filings/0001104659-25-107793.md) | [0.0](/filings/0001104659-26-024159.md) | not reported | not reported |
| Current portion of debt | $m | [12.6](/filings/0001558370-23-018008.md) | [120](/filings/0001558370-25-002405.md) | [0.0](/filings/0001558370-24-006566.md) | not reported | not reported | [1.9](/filings/0001104659-26-024159.md) | [1.9](/filings/0001558370-25-006998.md) | [1.9](/filings/0001558370-25-009892.md) | [2.0](/filings/0001104659-25-107793.md) | not reported | not reported | not reported |
| Shareholders' equity | $m | [291](/filings/0001558370-24-014902.md) | [292](/filings/0001104659-26-024159.md) | [310](/filings/0001104659-25-107793.md) | [307](/filings/0001104659-25-107793.md) | [308](/filings/0001104659-25-107793.md) | [233](/filings/0001104659-26-092074.md) | [229](/filings/0001104659-26-092074.md) | [225](/filings/0001104659-26-092074.md) | [226](/filings/0001104659-25-107793.md) | [196](/filings/0001104659-26-092074.md) | [194](/filings/0001104659-26-092074.md) | [198](/filings/0001104659-26-092074.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [0.1 d](/filings/0001558370-24-014902.md) | [14.5 d](/filings/0001104659-26-024159.md) | [(16.4)](/filings/0001558370-25-006998.md) | [0.8 d](/filings/0001558370-25-009892.md) | [(8.3) d](/filings/0001104659-25-107793.md) | [16.6 d](/filings/0001104659-26-024159.md) | [(2.1)](/filings/0001104659-26-057191.md) | [(9.4) d](/filings/0001104659-26-092074.md) | [(5.7) d](/filings/0001104659-25-107793.md) | [12.5 d](/filings/0001104659-26-024159.md) | [(4.1)](/filings/0001104659-26-057191.md) | [1.7 d](/filings/0001104659-26-092074.md) |
| Capital expenditure | $m | [0.8](/filings/0001558370-24-014902.md) | [1.2 d](/filings/0001104659-26-024159.md) | [1.9](/filings/0001558370-25-006998.md) | [1.6](/filings/0001558370-25-009892.md) | [1.1](/filings/0001104659-25-107793.md) | [2.2 d](/filings/0001104659-26-024159.md) | [1.2](/filings/0001104659-26-057191.md) | [1.9](/filings/0001558370-25-009892.md) | [1.2](/filings/0001104659-25-107793.md) | [0.9 d](/filings/0001104659-26-024159.md) | [1.6](/filings/0001104659-26-057191.md) | [1.1 d](/filings/0001104659-26-092074.md) |
| Dividends paid | $m | [0.9 d](/filings/0001558370-24-014902.md) | [1.0 d](/filings/0001104659-26-024159.md) | [1.0](/filings/0001558370-25-006998.md) | [1.0 d](/filings/0001558370-25-009892.md) | [1.0 d](/filings/0001104659-25-107793.md) | [1.0 d](/filings/0001104659-26-024159.md) | [1.0](/filings/0001104659-26-057191.md) | [1.0 d](/filings/0001104659-26-092074.md) | [1.0 d](/filings/0001104659-25-107793.md) | [1.0 d](/filings/0001104659-26-024159.md) | [1.0](/filings/0001104659-26-057191.md) | [1.0 d](/filings/0001104659-26-092074.md) |
| Share repurchases | $m | [0.0 d](/filings/0001558370-24-014902.md) | [0.0 d](/filings/0001104659-26-024159.md) | [0.2](/filings/0001558370-25-006998.md) | [0.0 d](/filings/0001558370-25-009892.md) | [0.0 d](/filings/0001104659-25-107793.md) | [0.0 d](/filings/0001104659-26-024159.md) | [0.0](/filings/0001104659-26-057191.md) | [0.0 d](/filings/0001104659-26-092074.md) | [0.0 d](/filings/0001104659-25-107793.md) | [0.0 d](/filings/0001104659-26-024159.md) | [0.0](/filings/0001104659-26-057191.md) | [0.4 d](/filings/0001104659-26-092074.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets, us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [39.6](/filings/0001558370-23-018008.md) | [37.1](/filings/0001558370-24-006566.md) | [37.2](/filings/0001558370-24-010612.md) | [37.5](/filings/0001558370-24-014902.md) | [38.2](/filings/0001558370-25-006998.md) | [38.3](/filings/0001558370-25-009892.md) | [38.4](/filings/0001104659-25-107793.md) | [38.4](/filings/0001104659-26-057191.md) | [38.4](/filings/0001104659-26-092074.md) | [38.4](/filings/0001104659-25-107793.md) | [38.4](/filings/0001104659-26-057191.md) | [38.4](/filings/0001104659-26-092074.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 38,288,155 at 2026-07-30, from the cover of the [10-Q filed 2026-08-06](/filings/0001104659-26-092074.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.